The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1--a review
- PMID: 16564911
- PMCID: PMC7112039
- DOI: 10.1016/j.humpath.2006.01.015
The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1--a review
Abstract
The pathology of 2 zoonotic human viral infections that recently emerged, severe acute respiratory syndrome (SARS) due to coronavirus (SARS-CoV) and avian influenza A subtype H5N1, is reviewed and compared based on the literature and the cases examined by the authors. Pneumocytes are the primary target of infection resulting in diffuse alveolar damage. Systemic cytokine activation results in hemophagocytic syndrome, lymphoid depletion, and skeletal muscle fiber necrosis. Severe acute respiratory syndrome induces a more fibrocellular intra-alveolar organization with a "bronchiolitis obliterans organizing pneumonia"-like pattern and presence of multinucleated histiocytes and pneumocytes. H5N1 causes a more fulminant and necrotizing diffuse alveolar damage with patchy and interstitial paucicellular fibrosis. Severe acute respiratory syndrome associated coronavirus persists in the lung up to the second month, whereas H5N1 persists in the lung up to the third week. Severe acute respiratory syndrome associated coronavirus disseminates to blood, urine, feces, gastrointestinal tract, and liver. There is recent report of possible cerebral involvement by H5N1 and its isolation in the blood, gastrointestinal tract, and cerebrospinal fluid. More pathologic studies are urgently needed.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7112039/bin/gr1.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7112039/bin/gr2.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7112039/bin/gr3.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7112039/bin/gr4.gif)
Similar articles
-
Systemic infection of avian influenza A virus H5N1 subtype in humans.Hum Pathol. 2009 May;40(5):735-9. doi: 10.1016/j.humpath.2008.08.015. Epub 2009 Jan 3. Hum Pathol. 2009. PMID: 19121843 Free PMC article.
-
Pathogenesis of avian flu H5N1 and SARS.Novartis Found Symp. 2006;279:56-60; discussion 60-5, 216-9. Novartis Found Symp. 2006. PMID: 17278385 Review.
-
The clinical presentation and outcomes of children infected with newly identified respiratory tract viruses.Infect Dis Clin North Am. 2005 Sep;19(3):569-84. doi: 10.1016/j.idc.2005.05.009. Infect Dis Clin North Am. 2005. PMID: 16102649 Free PMC article. Review.
-
Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS).J Clin Pathol. 2004 Mar;57(3):260-5. doi: 10.1136/jcp.2003.013276. J Clin Pathol. 2004. PMID: 14990596 Free PMC article.
-
Pathology of fatal human infection associated with avian influenza A H5N1 virus.J Med Virol. 2001 Mar;63(3):242-6. doi: 10.1002/1096-9071(200103)63:3<242::aid-jmv1007>3.0.co;2-n. J Med Virol. 2001. PMID: 11170064
Cited by
-
Lactoferrin Alleviates Inflammation and Regulates Gut Microbiota Composition in H5N1-Infected Mice.Nutrients. 2023 Jul 28;15(15):3362. doi: 10.3390/nu15153362. Nutrients. 2023. PMID: 37571299 Free PMC article.
-
Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy.Int J Mol Sci. 2022 Jul 19;23(14):7937. doi: 10.3390/ijms23147937. Int J Mol Sci. 2022. PMID: 35887283 Free PMC article.
-
Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19.Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211042940. doi: 10.1177/10760296211042940. Clin Appl Thromb Hemost. 2021. PMID: 34693754 Free PMC article. Review.
-
Complement Inhibition and COVID-19: The Story so Far.Immunotargets Ther. 2021 Jul 26;10:273-284. doi: 10.2147/ITT.S284830. eCollection 2021. Immunotargets Ther. 2021. PMID: 34345614 Free PMC article. Review.
-
Full Genomic Sequences of H5N1 Highly Pathogenic Avian Influenza Virus in Human Autopsy Specimens Reveal Genetic Variability and Adaptive Changes for Growth in MDCK Cell Cultures.Biomed Res Int. 2021 Jul 22;2021:3890681. doi: 10.1155/2021/3890681. eCollection 2021. Biomed Res Int. 2021. PMID: 34337007 Free PMC article.
References
-
- WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS). Updated recommendations, October 2004. World Health Organization [online] http://www.who.int/csr/resources/publications/WHO_CDS_CSR_ARO_2004_1/en/... Available at.
-
- Summary table of SARS cases by country, 1 November2002–7 August 2003. 15 August 2003. World Health Organization [online] http://www.who.int/csr/sars/country/2003_08_15/en/index.html Available at.
-
- Yuen K.Y., Chan P.K., Peiris M. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998;351:467–471. - PubMed
-
- World Health Organization Communicable disease surveillance and response. Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO, dated 30 December 2005 [online] http://www.who.int/csr/disease/avian_influenza/country/cases_table_2005_... Available at.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous